Backed by Science
Luminopia™ One is a digital therapeutic developed closely with leading physicians and neuroscientists that has been validated through a series of clinical trials, including a prospective, randomized controlled trial.
Luminopia One has been approved by the FDA for prescription use, and is indicated for improvement in visual acuity in amblyopia patients aged 4-7.